Skip to pipeline

ReprogrammingBiology

RedesigningLife

AI Native Platform for Innovative Medicines

0

Modalities

0+

Programs

0+

Scientists

0

Year Founded

Premise

Advanced Biology x AI

At Micro CRISPR, we believe the convergence of Advanced Biology and Artificial Intelligence has brought medicine to a defining inflection point; one that is poised to shape a new era in healthcare.

By building an integrated technology platform that can convert biological insight into transformative clinical outcomes; We exists to enable this change.

We envision a future in which medicines are increasingly programmable rather than discovered by chance, scalable rather than constrained by complexity, and accessible to all.

The architecture

Six biology platforms.
One AI native R&D stack

MicroCRISPR is built around a unified biological discovery and development architecture. Our six complementary biology modalities provide the technologies required to create the next generation of medicines. At the center of this architecture is Nuvo Labs, our AI-native intelligence engine, designed to identify high-value targets, engineer therapeutic candidates and optimize the path from discovery to development. Rather than operating six independent technology teams, each platform continuously generates data, insights, and learnings that strengthen the entire system.

Six platforms, One integrated intelligence, and A continuously learning therapeutic development Engine.

Our Biology Platforms
01 / 06
Biology platform

Cell Therapy

Engineered living cells

Next-generation cell therapy built on our proprietary engineering platform with plug-and-play synthetic modules for safety, potency and persistence, plus allogeneic-ready and in-vivo CAR programs.

In the portfolio
Programs
13
MOST ADVANCED PROGRAMS
CD19
Stage
Approved [India]
Every platform above draws on the engine below
NUVO Labs - The AI engine
Highlighted layers are the ones serving the selected platform
Foundation
Data
Single-cell, spatial, multi-omics, and proprietary experimental data.
Reasoning
NuDiscovery
Identify disease-relevant cell states, antigens and immune circuits, then generate optimal intervention strategies.
Creation
Generative
Design cellular programs, receptors and therapeutic constructs.
Evaluation
Scoring
Predict target coverage, activity, specificity, exhaustion, toxicity and therapeutic fitness.
Make
Retrosynthesis
Route ranking, cost and make-ability before chemistry.
What the engine does for Cell Therapy

The engine designs the construct and payload architecture, recommends which genes to modify for enhance persistence and exhaustion behavior, cleaner safety profile, etc

And the return path: every experiment this platform runs retrains the engine improving the other five

Nuvo Labs

Computational layer

Where AI meets Biology.

We combine AI, physics, chemistry, and biological intelligence to move from disease insight to novel molecules to real world validation.

NuDiscovery

Multi-Modal Disease understanding. Our Agentic system works as the guide to tap into the unknown

NuDiscovery platform

NuMol

Physics Grounded AI explorative method of unlocking unknown chemical spaces

NuMol platform

NuLabs

State of Art synthesis and BioLab facilities, Designed for AI native biology and effective feedback loops

NuLabs platform

Careers

Building the future of Human Health, Together

Biologist, Chemists and AI engineers running the same engine.

Open roles +

Partnership

A Platform, Open for collaboration

Built to discover, design to partner.